Sarah Price, Heidi A Hamann, Laila Halaby, Juanita Trejo, Fernanda Corella Rogers, Karen Weihs
{"title":"对癌症服务不足患者需求敏感的协作性抑郁症护理：可行性、可接受性和结果。","authors":"Sarah Price, Heidi A Hamann, Laila Halaby, Juanita Trejo, Fernanda Corella Rogers, Karen Weihs","doi":"10.1080/07347332.2023.2224314","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>A single-arm trial evaluated the feasibility, acceptability, and outcomes of COPE-D, a collaborative care intervention for underserved cancer patients with depression.</p><p><strong>Methods: </strong>Bilingual (Spanish and English) care managers provided counseling and/or medication management in consultation with physicians. Outcomes were <i>treatment improvement</i> (≥ 5-point reduction in PHQ-9), <i>treatment response</i> (≥ 50% reduction in PHQ-9), suicidal ideation resolution, and changes in depression (PHQ-9), anxiety (GAD-2), sleep disturbance (PSQI), global mental and physical health (PROMIS), social isolation (PROMIS), and qualitative feedback.</p><p><strong>Results: </strong>193 patients consented to participate. 165 initiated and 141 completed treatment, with 65% and 56% achieving treatment improvement and response, respectively. Outcomes did not differ by ethnicity (31% Hispanic), cancer stage (71% stages III-IV), income, or education. Suicidal ideation, depression, anxiety, sleep disturbance, and social isolation also improved. Qualitative feedback was largely positive.</p><p><strong>Conclusion: </strong>COPE-D improved depression and quality of life among underserved patients, with acceptable retention rates.</p>","PeriodicalId":47451,"journal":{"name":"Journal of Psychosocial Oncology","volume":" ","pages":"90-112"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739610/pdf/","citationCount":"0","resultStr":"{\"title\":\"Collaborative depression care sensitive to the needs of underserved patients with cancer: Feasibility, acceptability and outcomes.\",\"authors\":\"Sarah Price, Heidi A Hamann, Laila Halaby, Juanita Trejo, Fernanda Corella Rogers, Karen Weihs\",\"doi\":\"10.1080/07347332.2023.2224314\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>A single-arm trial evaluated the feasibility, acceptability, and outcomes of COPE-D, a collaborative care intervention for underserved cancer patients with depression.</p><p><strong>Methods: </strong>Bilingual (Spanish and English) care managers provided counseling and/or medication management in consultation with physicians. Outcomes were <i>treatment improvement</i> (≥ 5-point reduction in PHQ-9), <i>treatment response</i> (≥ 50% reduction in PHQ-9), suicidal ideation resolution, and changes in depression (PHQ-9), anxiety (GAD-2), sleep disturbance (PSQI), global mental and physical health (PROMIS), social isolation (PROMIS), and qualitative feedback.</p><p><strong>Results: </strong>193 patients consented to participate. 165 initiated and 141 completed treatment, with 65% and 56% achieving treatment improvement and response, respectively. Outcomes did not differ by ethnicity (31% Hispanic), cancer stage (71% stages III-IV), income, or education. Suicidal ideation, depression, anxiety, sleep disturbance, and social isolation also improved. Qualitative feedback was largely positive.</p><p><strong>Conclusion: </strong>COPE-D improved depression and quality of life among underserved patients, with acceptable retention rates.</p>\",\"PeriodicalId\":47451,\"journal\":{\"name\":\"Journal of Psychosocial Oncology\",\"volume\":\" \",\"pages\":\"90-112\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10739610/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Psychosocial Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/07347332.2023.2224314\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHOLOGY, SOCIAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosocial Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07347332.2023.2224314","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PSYCHOLOGY, SOCIAL","Score":null,"Total":0}
Collaborative depression care sensitive to the needs of underserved patients with cancer: Feasibility, acceptability and outcomes.
Purpose: A single-arm trial evaluated the feasibility, acceptability, and outcomes of COPE-D, a collaborative care intervention for underserved cancer patients with depression.
Methods: Bilingual (Spanish and English) care managers provided counseling and/or medication management in consultation with physicians. Outcomes were treatment improvement (≥ 5-point reduction in PHQ-9), treatment response (≥ 50% reduction in PHQ-9), suicidal ideation resolution, and changes in depression (PHQ-9), anxiety (GAD-2), sleep disturbance (PSQI), global mental and physical health (PROMIS), social isolation (PROMIS), and qualitative feedback.
Results: 193 patients consented to participate. 165 initiated and 141 completed treatment, with 65% and 56% achieving treatment improvement and response, respectively. Outcomes did not differ by ethnicity (31% Hispanic), cancer stage (71% stages III-IV), income, or education. Suicidal ideation, depression, anxiety, sleep disturbance, and social isolation also improved. Qualitative feedback was largely positive.
Conclusion: COPE-D improved depression and quality of life among underserved patients, with acceptable retention rates.
期刊介绍：
Here is your single source of integrated information on providing the best psychosocial care possible from the knowledge available from many disciplines.The Journal of Psychosocial Oncology is an essential source for up-to-date clinical and research material geared toward health professionals who provide psychosocial services to cancer patients, their families, and their caregivers. The journal—the first interdisciplinary resource of its kind—is in its third decade of examining exploratory and hypothesis testing and presenting program evaluation research on critical areas, including: the stigma of cancer; employment and personal problems facing cancer patients; patient education.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
